Sarepta Therapeutics, Inc. financial statements, including revenue, expenses, profit, and loss
The total revenue of SRPT for the last quarter is 396.78 M USD, and it's 19.58% higher compared to the previous quarter. The net income of Q4 23 is 45.66 M USD.